Results 221 to 230 of about 254,825 (362)
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions
ABSTRACT Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases worldwide. The clinical presentation of AD is heterogeneous and is characterized by a relapsing and remitting course. Most patients suffer from mild AD while approximately 5% to 20% experience severe disease activity, which often requires systemic treatment ...
Marjolein S. de Bruin‐Weller +9 more
wiley +1 more source
Analysis of Specific IgG4 Antibody and sIgG4/sIgE Antibody Ratio as Marker of Immune Tolerance to IgE-Mediated Response in Allergic Children. [PDF]
Kim H, Kang B, Choi BS.
europepmc +1 more source
Obesity Impairs Skin Barrier Function and Facilitates Allergic Sensitization in Mice
Diet‐induced obesity increases transepidermal water loss and compromises barrier function through downregulation of tight junctions and desmosomes. During obesity, MC903 elicits a mixed Th1/2/17 immune response in the skin leading to aggravated ear swelling.
Alicia Martinek +7 more
wiley +1 more source
Distinct Profiles of Patient-Reported Outcomes Across Allergen Signatures in Chronic Rhinosinusitis. [PDF]
Kim D, Jung CM, Cho HJ, Kim CH, Rha MS.
europepmc +1 more source
A phase 2 randomized controlled trial using biologics to improve multi OIT outcomes (COMBINE): design, rationale, and methods. [PDF]
Long AJ +27 more
europepmc +1 more source
Are all new allergens in
S. Echechipía +9 more
openalex +2 more sources
This prospective multicenter study corroborates the efficacy of AIT with the native HDM allergen extract in Chinese AR patients with diverse HDM sensitization patterns. HDM sensitization pattern affects the efficacy of AIT, with patients sensitized to both major and minor allergens of HDM showing improved outcomes with HDM SCIT.
Qingxiu Xu +14 more
wiley +1 more source

